Physician profile
Bruce Dixon
NPI 1932618162
$16,996.70
in general payments reported to CMS, 2019-2025
19 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,500 · 2022: $4,379 · 2023: $2,307 · 2024: $1,022 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,437 · Travel and Lodging: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,437.10 |
| Travel and Lodging | $1,680.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,747.58 | 2021-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $2,038.35 | 2022-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $1,772.79 | 2023-2025 | Wavewriter Alpha Prime 16, Infinion 16, General - Therapies |
| Vertos Medical, INC. | $535.47 | 2022-2023 | Mild Device Kit |
| Stryker Corporation | $335.35 | 2024-2025 | Optablate, Mild Device Kit, Omnicurve |
| Painteq LLC | $280.09 | 2022 | |
| Nevro Corp. | $263.09 | 2023-2024 | Senza |
| Curonix LLC | $252.54 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Avanos Medical | $247.24 | 2022-2025 | Coolief Cooled Radiofrequency, Coolief* Cooled Radiofrequency |
| Saluda Medical Americas, INC. | $152.92 | 2023 | Evoke Scs |
| Mml US, INC. | $109.04 | 2025 | Reactiv8 |
| Averitas Pharma INC. | $54.21 | 2023-2024 | Qutenza |
| Nalu Medical, INC. | $48.65 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $43.20 | 2022-2025 | |
| Relievant Medsystems, INC. | $30.35 | 2023 | Intracept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $22.27 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $21.67 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.99 | 2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $20.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.